OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2023
(2)
2022
(2)
2025
(1)
2024
(1)
2021
(1)
2020
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Visual vertical neglect in acquired brain injury: a systematic review.
Not available
S-EPMC10962212
|
biostudies-literature
Cite
Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.
Not available
S-EPMC8352775
|
biostudies-literature
Cite
Effect of a quality improvement program on compliance to the sepsis bundle in non-ICU patients: a multicenter prospective before and after cohort study.
Not available
S-EPMC10680451
|
biostudies-literature
Cite
Diagnostics of
BAP1
-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience.
Not available
S-EPMC9317020
|
biostudies-literature
Cite
The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.
Not available
S-EPMC9056437
|
biostudies-literature
Cite
Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation.
Not available
S-EPMC6489979
|
biostudies-literature
Cite
De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling.
Not available
S-EPMC10432144
|
biostudies-literature
Cite
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Not available
S-EPMC7576974
|
biostudies-literature
Cite
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12687902
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets